Source : Medtech Insight
The American Medical Association (AMA) has added two new Current Procedural Terminology (CPT) codes for reporting antigen tests that detect both COVID-19 and influenza.
Effective immediately, the new Category I CPT codes are 87636 and 87637.
These new codes “report nucleic acid assays that allow a single test to simultaneously detect the novel coronavirus and a combination of common viral infectious agents, including influenza A/B and respiratory syncytial virus,” AMA president Susan Bailey explained on 7 October. “Concurrent detection promises to conserve important testing resources, allowing for ongoing surveillance of influenza while testing for the novel coronavirus.”
Meanwhile, the AMA added a third new Category I code, 87811, for reporting “infectious agent antigen detection by immunoassay with direct visual observation.”
The AMA says other recent changes to the CPT code set in relation to COVID-19 can be found on the group’s website.
By Shawn M. Schmitt